Full Text View
Tabular View
No Study Results Posted
Related Studies
Safety & Radiation Distribution Study of Cotara® in Patients With Recurrent Glioblastoma Multiforme
This study is currently recruiting participants.
Study NCT00509301   Information provided by Peregrine Pharmaceuticals
First Received: July 27, 2007   Last Updated: January 8, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Recurrent Glioblastoma Multiforme
Additional conditions recognized in this trial
Glioblastoma
Recurrence
More general conditions related to this trial
Astrocytoma
Disease Attributes
Glioma
Neoplasms
Neoplasms by Histologic Type
Neoplasms, Germ Cell and Embryonal
Neoplasms, Glandular and Epithelial
Neoplasms, Nerve Tissue
Neoplasms, Neuroepithelial
Neuroectodermal Tumors
Pathologic Processes
Interventions listed in this trial
131-I-chTNT-1/B MAB
Sponsors listed in this trial
Peregrine Pharmaceuticals


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services